Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Quest Diagnostics    DGX

QUEST DIAGNOSTICS

(DGX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Analog Devices, AMC fall; Pfizer, Quest Diagnostics rise

share with twitter share with LinkedIn share with facebook
07/13/2020 | 05:56pm EDT

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Monday:

Analog Devices Inc., down $7.25 to $117.25.

The Norwood, Massachusetts chipmaker is buying rival Maxim Integrated Products in an all-stock deal worth $20 billion.

PepsiCo Inc., up 45 cents to $134.91.

The soda and snack maker beat Wall Street's fiscal second-quarter profit and revenue forecasts.

Tesla Inc., down $47.59 to $1,497.06.

The electric vehicle maker cut the starting price of its Model Y SUV, according to media reports.

AMC Entertainment Holdings Inc., down 34 cents to $4.26.

The movie theater chain announced a restructuring deal that will provide $300 million in financing.

Sirius XM Holdings Inc., down 11 cents to $5.59.

The satellite radio company is buying E.W. Scripps' podcast unit Stitcher.

Benefytt Technologies Inc., up $8.43 to $30.80.

The health insurance technology company is being bought by Madison Dearborn Partners.

Quest Diagnostics Inc., up $2.32 to $119.14.

The nationwide chain of clinical labs gave investors an encouraging second-quarter profit and revenue forecast.

Pfizer Inc., up $1.38 to $35.21.

Two of the drug company's potential coronavirus vaccines were given a “fast-track” designation by the U.S. government.

Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

Stocks mentioned in the article
ChangeLast1st jan.
AMC ENTERTAINMENT HOLDINGS, INC. 4.33% 5.54 Delayed Quote.-26.66%
ANALOG DEVICES -0.79% 117.18 Delayed Quote.0.32%
PFIZER, INC. -0.29% 38.06 Delayed Quote.-2.58%
QUEST DIAGNOSTICS -1.43% 120.01 Delayed Quote.14.01%
share with twitter share with LinkedIn share with facebook
Toute l'actualité sur QUEST DIAGNOSTICS
08/12QUEST DIAGNOSTICS : Releases Annual Environmental, Social & Governance Report
PR
08/10QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
08/03QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
08/03QUEST DIAGNOSTICS : Completes Acquisition of Mid America Clinical Laboratories, ..
PR
08/03QUEST DIAGNOSTICS : Launches Automated Next Generation Sequencing (NGS) Engine T..
PR
07/29QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
07/29QUEST DIAGNOSTICS : FDA Authorizes New Quest Diagnostics Lab Method Designed to ..
PR
07/27QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
07/24QUEST DIAGNOSTICS : Management's Discussion and Analysis of Financial Condition ..
AQ
07/23Quest medical lab sees COVID-19 test speed at 'acceptable' level by Sept
RE
More news
Financials (USD)
Sales 2020 8 686 M - -
Net income 2020 1 032 M - -
Net Debt 2020 3 529 M - -
P/E ratio 2020 15,9x
Yield 2020 1,85%
Capitalization 16 118 M 16 118 M -
EV / Sales 2020 2,26x
EV / Sales 2021 2,24x
Nbr of Employees 47 000
Free-Float 61,5%
Chart QUEST DIAGNOSTICS
Duration : Period :
Quest Diagnostics Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUEST DIAGNOSTICS
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 137,88 $
Last Close Price 120,01 $
Spread / Highest target 29,2%
Spread / Average Target 14,9%
Spread / Lowest Target -0,01%
EPS Revisions
Managers
NameTitle
Stephen H. Rusckowski Chairman, President & Chief Executive Officer
Mark J. Guinan Chief Financial Officer & Executive Vice President
Jay G. Wohlgemuth Chief Medical Officer, Senior VP-R&D, Medical
Gabrielle Wolfson SVP, Chief Information & Digital Officer
Gail R. Wilensky Independent Director
Sector and Competitors